LATINO, PAMELA
 Distribuzione geografica
Continente #
NA - Nord America 1.735
EU - Europa 139
AS - Asia 92
SA - Sud America 7
AF - Africa 1
OC - Oceania 1
Totale 1.975
Nazione #
US - Stati Uniti d'America 1.731
SG - Singapore 41
SE - Svezia 29
IN - India 28
UA - Ucraina 26
IT - Italia 22
DE - Germania 20
CN - Cina 19
FI - Finlandia 19
BG - Bulgaria 12
AR - Argentina 7
CA - Canada 3
IE - Irlanda 3
RO - Romania 3
IL - Israele 2
RU - Federazione Russa 2
BD - Bangladesh 1
CH - Svizzera 1
GB - Regno Unito 1
ID - Indonesia 1
LU - Lussemburgo 1
MX - Messico 1
NZ - Nuova Zelanda 1
TG - Togo 1
Totale 1.975
Città #
Fairfield 86
Woodbridge 52
Chandler 51
Ashburn 38
Seattle 37
Cambridge 34
Singapore 34
Houston 31
Dearborn 30
Wilmington 28
Princeton 16
Plano 14
Ann Arbor 12
Santa Clara 12
Sofia 12
Rome 10
San Diego 9
Beijing 8
Boston 8
Bremen 8
Jacksonville 8
Federal 7
Helsinki 7
Millbury 7
New York 7
Andover 6
Milan 6
Boardman 4
Lawrence 4
Des Moines 3
Dublin 3
Frankfurt am Main 3
Mannheim 3
Norwalk 3
Bühl 2
Falkenstein 2
Fremont 2
Hefei 2
Hyderabad 2
Moscow 2
Nanchang 2
Ottawa 2
Redmond 2
San Paolo di Civitate 2
Alatri 1
Auckland 1
Berlin 1
Buffalo 1
Chengdu 1
Dhaka 1
Falls Church 1
Guangzhou 1
Jakarta 1
Kunming 1
Lomé 1
Luxembourg 1
Mexico City 1
Munich 1
Philadelphia 1
Phoenix 1
Pune 1
Riva 1
San Jose 1
San Mateo 1
Southend 1
Toronto 1
Winterthur 1
Xian 1
Totale 645
Nome #
Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma. 1.219
Hypogonadism in DM1 and its relationship to erectile dysfunction 84
Botulinum toxin type A for Holmes tremor secondary to thalamic hemorrhage 83
The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study. 80
Erectile dysfunction in Myotonic Dystrophy type 1 (DM1) 78
Determinants of botulinum toxin discontinuation in multiple sclerosis. a retrospective study 68
Seropositive myasthenia gravis (MG): is there a changing trend in the age at onset? 64
ECG-Holter monitoring is a valuable tool to screen myotonic dystrophy type 1 (DM1) patients for advanced conduction defects. 55
null 54
Intracellular insulin mediated signalling in Myotonic Dystrophy type 1 (DM1) 52
Intracellular insulin mediated signaling in myotonic dystrophy type 1 46
Hypogonadism in myotonic dystrophy type 1 (DM1): its impact in patients’ sexual life 42
null 41
Metodo di studio della via intracellulare insulino-mediata nella Distrofia Miotonica tipo 1 (DM1) 26
Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions 14
Totale 2.006
Categoria #
all - tutte 3.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020133 0 0 0 0 0 39 31 20 21 10 8 4
2020/202155 7 5 7 5 0 6 2 5 6 5 6 1
2021/2022144 2 6 12 3 20 4 0 13 15 9 29 31
2022/2023151 33 20 6 23 21 16 3 7 17 0 3 2
2023/202491 5 15 0 13 4 21 0 7 0 13 4 9
2024/20251.179 1.068 69 4 9 19 10 0 0 0 0 0 0
Totale 2.006